These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3199608)

  • 1. Effects of platelet-activating factor on rat airways.
    Misawa M; Takata T
    Jpn J Pharmacol; 1988 Sep; 48(1):7-13. PubMed ID: 3199608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects.
    Roberts NM; McCusker M; Chung KF; Barnes PJ
    Br J Clin Pharmacol; 1988 Jul; 26(1):65-72. PubMed ID: 3203062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of PAF on isolated rat airways perfused with blood-free solution.
    Munoz NM; Kirchhoff CF; Strek ME; Blumenthal RN; Leff AR
    Am J Physiol; 1991 Apr; 260(4 Pt 1):L260-7. PubMed ID: 2018147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of airway narrowing caused by inhaled platelet-activating factor. Role of airway microvascular leakage.
    Tokuyama K; Lötvall JO; Barnes PJ; Chung KF
    Am Rev Respir Dis; 1991 Jun; 143(6):1345-9. PubMed ID: 2048823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of bronchoconstrictor responses to platelet-activating factor in the cat.
    Underwood DC; Kadowitz PJ
    J Appl Physiol (1985); 1989 Jul; 67(1):377-82. PubMed ID: 2759966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK; Strandhoy JW; Handa SE
    Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic activity of etizolam on platelet-activating factor in vivo experiments.
    Terasawa M; Mikashima H; Tahara T; Maruyama Y
    Jpn J Pharmacol; 1987 Aug; 44(4):381-6. PubMed ID: 3682404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bronchoconstrictor properties of platelet-activating factor in humans.
    Rubin AH; Smith LJ; Patterson R
    Am Rev Respir Dis; 1987 Nov; 136(5):1145-51. PubMed ID: 3314611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.
    Sirois MG; de Lima WT; de Brum Fernandes AJ; Johnson RJ; Plante GE; Sirois P
    Br J Pharmacol; 1994 Apr; 111(4):1111-6. PubMed ID: 8032597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for platelet-activating factor secretion during immune activation in dogs.
    Munoz NM; Stimler-Gerard NP; Mack MM; Tutins C; Blake JS; Kelly E; Murphy TM; Leff AR
    J Appl Physiol (1985); 1989 Apr; 66(4):1860-6. PubMed ID: 2732178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
    Dyson MC; Bellan JA; Minkes RK; Beckerman RC; Wegmann MJ; Braquet P; McNamara DB; Kadowitz PJ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1320-7. PubMed ID: 2175802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAF-induced bronchial hyperresponsiveness in the rabbit: contribution of platelets and airway smooth muscle.
    Coyle AJ; Spina D; Page CP
    Br J Pharmacol; 1990 Sep; 101(1):31-8. PubMed ID: 2282464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.
    Fabi F; Calabrese R; Stati T; del Basso P
    Br J Pharmacol; 2001 Oct; 134(4):777-88. PubMed ID: 11606318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple mechanisms of xanthine actions on airway reactivity.
    Howell RE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1008-14. PubMed ID: 2175791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body temperature modulates the effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit.
    Nieminen MM; Hill M; Irvin CG
    Agents Actions; 1991 Mar; 32(3-4):173-81. PubMed ID: 1862740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drugs if combined with anti-histamine and anti-serotonin agents interfere with the bronchial and platelet effects of "platelet-activating factor" (PAF-acether).
    Vargaftig BB; Lefort J; Wal F; Chignard M; Medeiros MC
    Eur J Pharmacol; 1982 Aug; 82(3-4):121-30. PubMed ID: 7128682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of pulmonary vasoconstriction and bronchoconstriction produced by PAF in the guinea-pig: role of platelets and cyclo-oxygenase metabolites.
    Argiolas L; Fabi F; del Basso P
    Br J Pharmacol; 1995 Jan; 114(1):203-9. PubMed ID: 7712019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways.
    Johnson PR; Armour CL; Black JL
    Eur Respir J; 1990 Jan; 3(1):55-60. PubMed ID: 2311732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.